Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caregivers During the COVID-19 Pandemic
  • +3
  • Nancy Green,
  • Deepa Manwani,
  • Kim Smith-Whitley,
  • Banu Aygun,
  • Abena Appiah-Kubi,
  • Arlene Smaldone
Nancy Green
Columbia University

Corresponding Author:[email protected]

Author Profile
Deepa Manwani
Children's Hospital at Montefiore
Author Profile
Kim Smith-Whitley
The Children's Hospital of Philadelphia
Author Profile
Banu Aygun
Steven and Alexandra Cohen Children's Medical Center
Author Profile
Abena Appiah-Kubi
Steven and Alexandra Cohen Children's Medical Center
Author Profile
Arlene Smaldone
Columbia University Irving Medical Center
Author Profile

Abstract

Youth with sickle cell disease (SCD) and their caregivers are susceptible to stress and depression, perhaps exacerbated by pandemic-associated health and economic concerns. Most of the 50 youth-caregiver dyads enrolled in the multi-site HABIT trial took an on-line survey of self-reported mental health symptoms and food insecurity during the 2020 COVID-19 pandemic. Compared to largely pre-pandemic results, prevalence of mental health symptoms in dyad members appeared to have shifted: fewer youth and more caregivers were affected during the pandemic; many of both groups lacked optimism. Pandemic screening of youth with SCD for mental health symptoms and food insecurity appears warranted.
03 Jan 2022Submitted to Pediatric Blood & Cancer
03 Jan 2022Submission Checks Completed
03 Jan 2022Assigned to Editor
04 Jan 2022Reviewer(s) Assigned
15 Feb 2022Review(s) Completed, Editorial Evaluation Pending
15 Feb 2022Editorial Decision: Revise Major
22 Mar 20221st Revision Received
22 Mar 2022Submission Checks Completed
22 Mar 2022Assigned to Editor
23 Mar 2022Reviewer(s) Assigned
14 Apr 2022Review(s) Completed, Editorial Evaluation Pending
14 Apr 2022Editorial Decision: Revise Minor
21 Apr 20222nd Revision Received
21 Apr 2022Submission Checks Completed
21 Apr 2022Assigned to Editor
22 Apr 2022Reviewer(s) Assigned
06 May 2022Review(s) Completed, Editorial Evaluation Pending
06 May 2022Editorial Decision: Accept
Sep 2022Published in Pediatric Blood & Cancer volume 69 issue 9. 10.1002/pbc.29797